Hc Advisors, LLC Crispr Therapeutics Ag Transaction History

Hc Advisors, LLC

$117 Million
Q3 2024

A detailed history of Hc Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Hc Advisors, LLC holds 4,319 shares of CRSP stock, worth $191,029. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,319

Previous 4,185 3.2%

Holding current value

$191,029

Previous $226,000 10.62%

% of portfolio

0.17%

Previous 0.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$44.62 - $62.75 $5,979 - $8,408	134 Added 3.2%	4,319 $202,000
Q2 2024 Aug 07, 2024	SELL	$51.17 - $68.18 $14,327 - $19,090	-280 Reduced 6.27%	4,185 $226,000
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $9,585 - $14,080	158 Added 3.67%	4,465 $304,000
Q4 2023 Jan 25, 2024	BUY	$38.62 - $72.18 $166,336 - $310,879	4,307 New	4,307 $269,000
Q2 2023 Aug 10, 2023	SELL	$43.47 - $67.77 $29,168 - $45,473	-671 Reduced 14.34%	4,008 $225,000
Q1 2023 May 08, 2023	SELL	$41.0 - $56.12 $25,502 - $34,906	-622 Reduced 11.73%	4,679 $211,000
Q4 2022 Feb 08, 2023	SELL	$39.19 - $65.67 $1.91 Million - $3.19 Million	-48,643 Reduced 90.17%	5,301 $215,000
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $2.84 Million - $3.9 Million	46,512 Added 625.83%	53,944 $3.53 Million
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $6,657 - $11,369	154 Added 2.12%	7,432 $452,000
Q1 2022 May 06, 2022	SELL	$53.19 - $79.24 $64,413 - $95,959	-1,211 Reduced 14.27%	7,278 $457,000
Q4 2021 Feb 02, 2022	BUY	$70.09 - $111.29 $191,976 - $304,823	2,739 Added 47.63%	8,489 $643,000
Q3 2021 Oct 29, 2021	BUY	$110.2 - $156.64 $4,738 - $6,735	43 Added 0.75%	5,750 $644,000
Q2 2021 Aug 09, 2021	BUY	$100.84 - $161.89 $108,604 - $174,355	1,077 Added 23.26%	5,707 $924,000
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $45,616 - $86,536	412 Added 9.77%	4,630 $564,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $30,911 - $67,213	388 Added 10.13%	4,218 $646,000
Q3 2020 Nov 04, 2020	BUY	$78.5 - $100.64 $13,580 - $17,410	173 Added 4.73%	3,830 $320,000
Q2 2020 Aug 12, 2020	BUY	$38.5 - $76.05 $140,794 - $278,114	3,657 New	3,657 $269,000

Others Institutions Holding CRSP

# of Institutions

487

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.45B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hc Advisors, LLC with notifications on news.

Account